Ontology highlight
ABSTRACT:
SUBMITTER: Sethi S
PROVIDER: S-EPMC7052452 | biostudies-literature | 2020 Jan-Dec
REPOSITORIES: biostudies-literature
Sethi Sanjay S Donohue James F JF Ferguson Gary T GT Barnes Chris N CN Crater Glenn D GD
Therapeutic advances in respiratory disease 20200101
<h4>Background</h4>Combinations of a long-acting muscarinic receptor antagonist (LAMA), long-acting β-agonist (LABA), and inhaled corticosteroid (ICS) are used for patients with persistent chronic obstructive pulmonary disease (COPD) exacerbations on bronchodilator monotherapy. In this prespecified subgroup analysis, we assessed the efficacy and safety of the LAMA revefenacin in patients with COPD taking concomitant LABA, including ICS/LABA (LABA subgroup).<h4>Methods</h4>Efficacy data were obta ...[more]